Organon (OGN) Gross Margin (2020 - 2026)

Organon (OGN) posted quarterly Gross Margin of 53.63% for Q1 2026, down 195.0% year-over-year from 56.45% in Q1 2025, and up 9.07% on a QoQ basis from 49.17% in Q4 2025.

Organon (OGN) Gross Margin (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Gross Margin for 7 consecutive years, with 53.63% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gross Margin fell 195.0% year-over-year to 53.63%; the TTM figure through Mar 2026 stood at 52.82% (down 437.0% YoY), while the FY2025 annual figure was 53.3%, down 472.0% from the prior year.
  • Gross Margin came in at 53.63% for Q1 2026 at Organon, up from 49.17% in the prior quarter.
  • The five-year high for Gross Margin was 64.2% in Q1 2022, with the low at 49.17% in Q4 2025.
  • Average Gross Margin over 5 years is 58.2%, with a median of 58.43% recorded in 2024.
  • Across the five-year window, Gross Margin jumped 344 bps in 2022 and slumped 711 bps in 2025, its largest moves.
  • Year by year, Gross Margin stood at 60.0% in 2022, then slipped by 5 bps to 57.26% in 2023, then declined by 2 bps to 56.28% in 2024, then declined by 13 bps to 49.17% in 2025, then advanced by 9 bps to 53.63% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods registered 53.63%, 49.17%, and 53.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 81.93%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 66.31%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 71.88%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 87.65%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 74.24%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 68.16%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 79.24%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -51.69%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 53.63%

Historic Data

Download Data
DateValue
Mar 31, 2026 53.63%
Dec 31, 2025 49.17%
Sep 30, 2025 53.50%
Jun 30, 2025 54.83%
Mar 31, 2025 55.58%
Dec 31, 2024 56.28%
Sep 30, 2024 58.34%
Jun 30, 2024 58.43%
Mar 31, 2024 59.00%
Dec 31, 2023 57.26%
Sep 30, 2023 59.71%
Jun 30, 2023 60.20%
Mar 31, 2023 62.29%
Dec 31, 2022 60.00%
Sep 30, 2022 64.15%
Jun 30, 2022 62.90%
Mar 31, 2022 64.20%
Dec 31, 2021 62.63%
Sep 30, 2021 61.94%
Jun 30, 2021 63.45%